S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead

iTeos Therapeutics (ITOS) Insider Trading & Ownership

$11.76
+0.04 (+0.34%)
(As of 04/15/2024 ET)

iTeos Therapeutics (NASDAQ:ITOS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
10.20%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$41,850.00
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$5.69 M
Get ITOS Insider Trade Alerts

Want to know when executives and insiders are buying or selling iTeos Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ITOS Insider Buying and Selling by Quarter

iTeos Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/12/2023Matthew GallCFOBuy5,000$8.37$41,850.00  
8/23/2023Boxer Capital, LlcInsiderSell350,000$16.26$5,691,000.00  
(Data available from 1/1/2013 forward)

ITOS Insider Trading Activity - Frequently Asked Questions

Who is on iTeos Therapeutics's Insider Roster?

The list of insiders at iTeos Therapeutics includes Aaron I Davis, Ansbert Gadicke, Bioventures 2014 L.P. Mpm, Bioventures 2018 L.P. Mpm, Boxer Capital, Llc, David Hallal, Detlev Biniszkiewicz, Joanne Jenkins Lager, Matthew Gall, Michel Detheux, and Yvonne Mcgrath. Learn more on insiders at ITOS.

What percentage of iTeos Therapeutics stock is owned by insiders?

10.20% of iTeos Therapeutics stock is owned by insiders. Learn more on ITOS's insider holdings.

Which iTeos Therapeutics insiders have been buying company stock?

The following insider purchased ITOS shares in the last 24 months: Matthew Gall ($41,850.00).

How much insider buying is happening at iTeos Therapeutics?

Insiders have purchased a total of 5,000 ITOS shares in the last 24 months for a total of $41,850.00 bought.

Which iTeos Therapeutics insiders have been selling company stock?

The following insiders have sold ITOS shares in the last 24 months: Aaron I Davis ($18,292,500.00), Boxer Capital, Llc ($5,691,000.00), David Hallal ($22,846.21), and Michel Detheux ($366,505.00).

How much insider selling is happening at iTeos Therapeutics?

Insiders have sold a total of 1,175,671 iTeos Therapeutics shares in the last 24 months for a total of $24,372,851.21 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:ITOS) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners